M. Roberts (London, United Kingdom), S. Hartl (Vienna, Austria)
A systematic review of cost-effectiveness and quality derived from models evaluating smoking cessation interventions in patients with COPD F. Kirsch (Munich, Germany)
| |
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia S. Spoorenberg, W. J. Bos, R. Heijligenberg, P. Voorn, J. Grutters, G. Rijkers, E. Van de Garde (Nieuwegein, Ede, Netherlands)
| |
The impact of miscoding of community -acquired pneumonia in a UK district general hospital N. Gildeh, T. Errington, I. Maxwell, S. Merritt, D. Maxwell, O. Kankam (St Leonards on Sea, United Kingdom)
| |
Medication reconciliation as warranty of improvement in patient care L. Saldaña, M. C. Herrero, M. V. Hernández, B. Steen, S. Sanz, M. Izquierdo, E. Pérez-F (Madrid, Spain)
| |
Transcutaneous pCO2 monitoring as an alternative to arterial line sampling: A cost-effectiveness analysis J. van Oppen, M. Sovani (Nottingham, United Kingdom)
| |